Sio Gene Therapies, Inc. (SIOX) Social Stream
SIO GENE THERAPIES INC (SIOX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering SIOX.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
SIOX's average price target has moved down $2.33 over the prior 17 months.
Over the past 48 days, SIOX's average upside potential has been 1,984.97%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
SIOX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
SIOX's average broker recommendation rating worsened by 1.67 over the prior 13 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, SIO GENE THERAPIES INC's upside potential (average analyst target price relative to current price) is higher than 685.09% of them.
- SIO GENE THERAPIES INC's variance in analysts' estimates is lower than -564.01% of all US stocks.
- SIO GENE THERAPIES INC's average analyst price target is higher than 38.5% of stocks in the mid market cap category.
- In the context of stocks in the mid market cap category, SIO GENE THERAPIES INC's number of analysts covering the stock is greater than 130.71% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to SIO GENE THERAPIES INC are ASND, QURE, and KDNY.
View All Top Stocks by Price Target
Make investment decisions regarding SIOX using the data that counts. Try POWR Ratings for free.